These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
967 related articles for article (PubMed ID: 29505836)
21. MicroRNA-370 Regulates Cellepithelial-Mesenchymal Transition, Migration, Invasion, and Prognosis of Hepatocellular Carcinoma by Targeting GUCD1. He Y; He X Yonsei Med J; 2019 Mar; 60(3):267-276. PubMed ID: 30799589 [TBL] [Abstract][Full Text] [Related]
22. MicroRNA-98-5p Inhibits Tumorigenesis of Hepatitis B Virus-Related Hepatocellular Carcinoma by Targeting NF-κB-Inducing Kinase. Fei X; Zhang P; Pan Y; Liu Y Yonsei Med J; 2020 Jun; 61(6):460-470. PubMed ID: 32469170 [TBL] [Abstract][Full Text] [Related]
23. Increased expression of microRNA-31-5p inhibits cell proliferation, migration, and invasion via regulating Sp1 transcription factor in HepG2 hepatocellular carcinoma cell line. Zhao G; Han C; Zhang Z; Wang L; Xu J Biochem Biophys Res Commun; 2017 Aug; 490(2):371-377. PubMed ID: 28623129 [TBL] [Abstract][Full Text] [Related]
24. Direct targeting sperm-associated antigen 9 by miR-141 influences hepatocellular carcinoma cell growth and metastasis via JNK pathway. Lou G; Dong X; Xia C; Ye B; Yan Q; Wu S; Yu Y; Liu F; Zheng M; Chen Z; Liu Y J Exp Clin Cancer Res; 2016 Jan; 35():14. PubMed ID: 26790956 [TBL] [Abstract][Full Text] [Related]
25. MicroRNA-144 inhibits hepatocellular carcinoma cell proliferation, invasion and migration by targeting ZFX. Bao H; Li X; Li H; Xing H; Xu B; Zhang X; Liu Z J Biosci; 2017 Mar; 42(1):103-111. PubMed ID: 28229969 [TBL] [Abstract][Full Text] [Related]
26. miR-129 suppresses tumor cell growth and invasion by targeting PAK5 in hepatocellular carcinoma. Zhai J; Qu S; Li X; Zhong J; Chen X; Qu Z; Wu D Biochem Biophys Res Commun; 2015 Aug; 464(1):161-7. PubMed ID: 26116538 [TBL] [Abstract][Full Text] [Related]
27. Regulation of tumorigenesis and metastasis of hepatocellular carcinoma tumor endothelial cells by microRNA-3178 and underlying mechanism. Li W; Shen S; Wu S; Chen Z; Hu C; Yan R Biochem Biophys Res Commun; 2015 Aug; 464(3):881-7. PubMed ID: 26182877 [TBL] [Abstract][Full Text] [Related]
28. microRNA-146a inhibits cancer metastasis by downregulating VEGF through dual pathways in hepatocellular carcinoma. Zhang Z; Zhang Y; Sun XX; Ma X; Chen ZN Mol Cancer; 2015 Jan; 14():5. PubMed ID: 25608619 [TBL] [Abstract][Full Text] [Related]
29. miR-345 inhibits tumor metastasis and EMT by targeting IRF1-mediated mTOR/STAT3/AKT pathway in hepatocellular carcinoma. Yu M; Xue H; Wang Y; Shen Q; Jiang Q; Zhang X; Li K; Jia M; Jia J; Xu J; Tian Y Int J Oncol; 2017 Mar; 50(3):975-983. PubMed ID: 28098858 [TBL] [Abstract][Full Text] [Related]
30. miR-139-5p inhibits epithelial-mesenchymal transition, migration and invasion of hepatocellular carcinoma cells by targeting ZEB1 and ZEB2. Qiu G; Lin Y; Zhang H; Wu D Biochem Biophys Res Commun; 2015 Jul; 463(3):315-21. PubMed ID: 26022123 [TBL] [Abstract][Full Text] [Related]
31. miR-139 regulates the proliferation and invasion of hepatocellular carcinoma through the WNT/TCF-4 pathway. Gu W; Li X; Wang J Oncol Rep; 2014 Jan; 31(1):397-404. PubMed ID: 24190507 [TBL] [Abstract][Full Text] [Related]
32. miR-493-5p suppresses hepatocellular carcinoma cell proliferation through targeting GP73. Zhao J; Xu T; Wang F; Cai W; Chen L Biomed Pharmacother; 2017 Jun; 90():744-751. PubMed ID: 28419971 [TBL] [Abstract][Full Text] [Related]
33. MicroRNA-206, down-regulated in hepatocellular carcinoma, suppresses cell proliferation and promotes apoptosis. Yunqiao L; Vanke H; Jun X; Tangmeng G Hepatogastroenterology; 2014; 61(133):1302-7. PubMed ID: 25436301 [TBL] [Abstract][Full Text] [Related]
34. MicroRNA-15a-5p suppresses cancer proliferation and division in human hepatocellular carcinoma by targeting BDNF. Long J; Jiang C; Liu B; Fang S; Kuang M Tumour Biol; 2016 May; 37(5):5821-8. PubMed ID: 26581909 [TBL] [Abstract][Full Text] [Related]
35. MicroRNA-608 acts as a prognostic marker and inhibits the cell proliferation in hepatocellular carcinoma by macrophage migration inhibitory factor. Wang K; Liang Q; Wei L; Zhang W; Zhu P Tumour Biol; 2016 Mar; 37(3):3823-30. PubMed ID: 26474589 [TBL] [Abstract][Full Text] [Related]
36. miR-10b exerts oncogenic activity in human hepatocellular carcinoma cells by targeting expression of CUB and sushi multiple domains 1 (CSMD1). Zhu Q; Gong L; Wang J; Tu Q; Yao L; Zhang JR; Han XJ; Zhu SJ; Wang SM; Li YH; Zhang W BMC Cancer; 2016 Oct; 16(1):806. PubMed ID: 27756250 [TBL] [Abstract][Full Text] [Related]
37. miR-361-5p inhibits hepatocellular carcinoma cell proliferation and invasion by targeting VEGFA. Cui W; Li Y; Xu K; Chen G; Lu X; Duan Q; Kang Z Biochem Biophys Res Commun; 2016 Oct; 479(4):901-906. PubMed ID: 27641667 [TBL] [Abstract][Full Text] [Related]
38. Downregulation of miR-329 promotes cell invasion by regulating BRD4 and predicts poor prognosis in hepatocellular carcinoma. Zhou J; Li W; Guo J; Li G; Chen F; Zhou J Tumour Biol; 2016 Mar; 37(3):3561-9. PubMed ID: 26456956 [TBL] [Abstract][Full Text] [Related]
39. MiR-26b inhibits hepatocellular carcinoma cell proliferation, migration, and invasion by targeting EphA2. Li H; Sun Q; Han B; Yu X; Hu B; Hu S Int J Clin Exp Pathol; 2015; 8(5):4782-90. PubMed ID: 26191168 [TBL] [Abstract][Full Text] [Related]
40. MicroRNA-101 inhibits human hepatocellular carcinoma progression through EZH2 downregulation and increased cytostatic drug sensitivity. Xu L; Beckebaum S; Iacob S; Wu G; Kaiser GM; Radtke A; Liu C; Kabar I; Schmidt HH; Zhang X; Lu M; Cicinnati VR J Hepatol; 2014 Mar; 60(3):590-8. PubMed ID: 24211739 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]